The NLRP3 inflammasome in gynecological cancers: a double-edged sword shaping the immune microenvironment and immunotherapy response - Takeaways - MDSpire

The Role of the NLRP3 Inflammasome in Gynecological Cancers: Balancing Immune Microenvironment Dynamics and Responses to Immunotherapy

By
Yibo He
Shiyue Wu
Zian Shou
Qian Guo
Yaonan Hong
Lianfang Zhao
Jie Wang
June 24, 2026

Frontiers In Immunology

Share

1

The NLRP3 inflammasome plays a dual role in gynecological cancers, influencing both immune suppression and responses to immunotherapy.
2

In ovarian cancer, NLRP3 promotes immune suppression while enhancing cisplatin sensitivity through pyroptotic signaling.
3

Endometrial cancer shows a context-dependent role of NLRP3, with pro-immune effects in MSI-H tumors and potentially pro-tumorigenic effects in microsatellite-stable subtypes.
4

Cervical cancer utilizes HPV oncoproteins to silence NLRP3, evading immune surveillance through multiple mechanisms.
5

The PD-L1/NLRP3 axis contributes to resistance against anti-PD-1 immunotherapy, highlighting the need for novel immunomodulatory strategies.

Original Source(s)

Frontiers In Immunology

The NLRP3 inflammasome in gynecological cancers: a double-edged sword shaping the immune microenvironment and immunotherapy response

by Yibo He, Shiyue Wu, Zian Shou, Qian Guo, Yaonan Hong, Lianfang Zhao, Jie Wang
June 24, 2026

Related Content

Gut

Correction: Blockade of interleukin 10 potentiates antitumour immune function in human colorectal cancer liver metastases

August 1, 2026

Frontiers In Oncology

Correction: Serial ctDNA dynamics predict clinical outcomes in metastatic and locally advanced PDAC: a systematic review

Baptist Health South Florida

Updated ASTRO Guideline Reflects a New Era for Radiation Therapy in Pancreatic Cancer

An updated clinical practice guideline from the American Society for Radiation Oncology substantially expands and modernizes recommendations for the use of radiation therapy in pancreatic cancer.

by
August 14, 2026
6 min